Flosonics is a medical device company focused on developing non-invasive sensors to improve the management of critically ill patients. Flosonics Medical’s flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit.
Bluetooth connectivity to tablet, phone or other medical equipment.
COST EFFECTIVE DISPOSABLE ULTRASOUND BANDAGE
Low cost disposable reduces the requirement of expensive capital purchases and maintenance.
FUNCTIONAL HEMODYNAMIC MONITORING
Determine fluid responsiveness in under 30 seconds.
Continuous monitoring of arterial flow with automatic artery detection.
IMPROVE PHYSICIAN WORKFLOWS
Hands free with simple push-button functionality. Small, portable and wireless.
REMOVE TECHNICAL BARRIERS
Purpose built to be easily used by physicians, nurses and paramedics.
Dr. Joe Eibl
CEO & Co-Founder
Dr. Eibl is responsible for the growth and development of technology, intellectual property and business strategy. Dr. Eibl holds a PhD in Biomolecular Sciences and he has conducted postdoctoral training in the field of bioengineering.
Dr. Jon-Emile Kenny
Chief Medical Officer & Co-Founder
Dr. Kenny obtained his M.D. at the University of Toronto. He completed his residency and chief residency in general internal medicine at NYU-Langone Medical Center. He completed his fellowship in pulmonary & critical care medicine at Stanford University Medical Center. Dr. Kenny is also the founder of Heart-Lung.org (a critical medical education website), and he is the Senior Contributing Editor for PulmCCM. Dr. Kenny will lead clinical evaluation, functionality and 510K certification of technology for approval by the Food and Drug Administration.
Director of Operations & Co-Founder
Mr. Andrew Eibl holds a Bachelor of Commerce from the University of Ottawa, and is currently pursuing the Canadian Human Resources Professional Designation. Mr. Eibl has over 7 years of experience in healthcare data analytics, human resources, project management, and business development. Previously, he managed a Human Resource Information System with over 2000 employees, and was a Data Specialist for health case costing at Health Sciences North.
Sachit Harish, CPA, CA
Director of Finance and Co-Founder
Mr. Sachit Harish is a Chartered Professional Accountant (CPA, CA) with a strong background in start-up financing and growth. He previously spent over 5 years auditing a wide range of real estate, high-tech, manufacturing and private corporations at Deloitte LLP. More recently, he has worked in companies ranging from large high-tech corporations, to residential home-builders, in addition to assisting with the startup and growth of a cryptocurrency company.
EVP, Business and Clinical Development
Mr. Pankratz built a medtech company that was successfully acquired by a global medical device company. Previously, he helped build the surgical division of medical device company and the launch of several medical devices in Canada. Prior to that, he worked in Development Operations at Amgen. Stephen has experience raising early-stage capital, medical device development, clinical development, negotiations with and on behalf of multinational companies and with hospital procurement groups, device sales and management, business development, investments and acquisitions. Mr. Pankratz holds a Bachelor of Science (Honours) in life sciences from Queen’s University, and received his Masters in Biotechnology from the University of Toronto.
Mr. Pietro Verrecchia assists with product development and technical validation. He holds an Honours Electrical Engineering degree from McGill University. His experience includes engineering internships at the MIT Lincoln Laboratory and work as a program manager at Microsoft.
Dr. Paul Magnin – Chairman of the Board
Paul Magnin spent 17 years as a key contributor to Hewlett-Packard’s Ultrasound Imaging business, and he is credited with inventing color flow Doppler imaging. He was the R&D Manager of Hewlett-Packard’s Imaging Systems business from 1992 through 1995 and General Manager from 1996 through 1998. From 1999 through 2003, Dr. Magnin was the President and CEO of LightLab Imaging. LightLab Imaging, a medical device start-up company, brought to market a proprietary technology that employs infrared light to make images with resolution on the micron scale for Cardiology, Endoscopy, Neurology, and Surgical Microscopy. He managed the company from the start-up phase through the sale of the company to Goodman Ltd. Subsequently he was the Founder and CEO of Novelis, Inc. a privately funded start-up focused on guiding therapy for Interventional Cardiology applications. Novelis was sold to Volcano Corporation in 2008.
Dr. Magnin is an advisor and board member of a number of medical device start-up companies and was the Chairman of the Board of Directors of Ultrasonix Medical Corp. in Vancouver, BC. He holds over 20 patents and has authored over 20 scientific journal articles. He has been studying and working in medical imaging since 1977 while an undergraduate at Princeton University. In 1981 he completed his doctorate in Biomedical Engineering at Duke University where he was part of the Ultrasonic Imaging research team.
Dr. Stuart Foster – Director
Stuart Foster is currently a senior scientist at Sunnybrook Research Institute and Professor and Canada Research Chair in Ultrasound Imaging, Department of Medical Biophysics at the University of Toronto. His current research centers on the development of high frequency clinical and preclinical imaging systems, array technology, intravascular imaging, photo acoustics, and molecular imaging. Stuart is a fellow of the American Institute of Ultrasound in Medicine and IEEE. He is the founder and former Chairman of VisualSonics Inc. which manufactures imaging equipment considered to be the gold standard in high frequency ultrasound. VisualSonics is now part of the Fujifilm group of companies. Dr. Foster co-founded the Mouse Imaging Centre (MICe) now at the Toronto Centre for Phenogenomics. He has served on the Board of Directors of the National Cancer Institute of Canada and as Chairman of its Committee on Research (ACOR). He has previously been the recipient of the Eadie Medal for major contributions to engineering in Canada and has been the recipient of the Queen’s Golden Jubilee Medal, the Manning Award of Distinction for Canadian Innovation and the Ontario Premier’s Discovery Award. He serves on numerous advisory bodies and is currently on the editorial boards of Ultrasonic Imaging and Ultrasound in Medicine and Biology. Dr. Foster was the recipient of the 2010 Rayleigh Award from IEEE.
Sam has over 20 years of entrepreneurial, technology and venture capital experience. As Managing Partner of the iGan Partners team, he is involved in the evaluation, structuring, execution, and monitoring of iGan’s investments. Sam has been extensively involved with several companies, often serving as CEO, particularly in the early stages of each company’s development. Prior to founding iGan Partners, he co-founded several companies including Visualsonics, Tri-Link Technologies and Brighter Minds. Prior to that he was a strategy consultant with Mercer Management Consulting (now Oliver Wyman) where he advised Fortune 500 companies on corporate strategy. Sam has also held general management roles at NCR, where he led the deployment of enterprise-grade information technology systems.
Sam holds an MBA from the John Molson School of Business and a Bachelor of Electrical Engineering from McGill University.
Damian Lamb – Director
Mr. Lamb is co-Founder and Managing Director of Genesys Capital. He brings a unique experience base, blending skills in both the commercial and technical side of biotechnology. Since co-founding Genesys Capital in 2000, Mr. Lamb has been instrumental in raising over $300 million in venture capital funds, and has been involved in deploying over $160 million across 29 investments. He currently serves on the Boards of Affinium Pharmaceuticals Inc., Fusion Pharmaceuticals, Profound Medical Inc. (TSX: PRN) and the Centre for Probe Development and Commercialization at McMaster University. He has served on the Board of Ionalytics Corporation (acquired by Thermo Electron Corp.), Millenium Biologix (acquired by Medtronic) and was Chairman of the Board of DELEX Therapeutics Inc. when it was sold to YM BioSciences (now Gilead). Mr. Lamb works closely with Genesys investee companies to strategically position the companies to build value for shareholders.
Prior to co-founding Genesys Capital, Mr. Lamb was an Investment Manager with MDS Capital Corp. He is a frequently invited speaker at biotechnology industry conferences.
Mr. Lamb graduated from McMaster University, Faculty of Health Sciences, with a Master of Science in Molecular Neurobiology and also holds an MBA from Queen’s University.
Dr. Joe Eibl
Dr. Joe Eibl is the CEO and Co-founder of Flosonics Medical.
Scientific Advisory Board
Dr. Jean-Louis Teboul
Jean-Louis Teboul, MD, PhD is Professor of Therapeutics and Critical Care Medicine, at the University Paris-South in France. He exerts his clinical activity at the Medical ICU of the Bicêtre University Hospital (Assistance-Publique Hôpitaux de Paris). His research interests are the following: heart-lung interactions, cardiovascular performance, regional blood flow assessment, tissue oxygenation, haemodynamic monitoring, and assessment of volume status in critically ill patients. He proposed and developed new tests to assess fluid responsiveness such as Pulse Pressure Variation and Passive Leg Raising, which are now used everywhere around the world. He has 213 articles (referenced in Pubmed) and around 126 book chapters/didactic articles, almost of them in the field of haemodynamics. He gave 790 invited lectures including 618 in international conferences. He is currently the Editor-in-Chief of Annals of Intensive Care. He received in 2007 the Honorary Fellow Honor Award of the American College of Chest Physicians.
Dr. Xavier Monnet
Xavier MONNET is Professor of Intensive Care at the Paris-Sud University. He works in the Medical Intensive Care Unit of the Bicêtre Hospital (Paris-Sud University Hospitals).
Dr Monnet completed his medical studies at the Paris-6 Medical School and he earned his medical degree in 2000, with specialty in Cardiology and Intensive Care Medicine. In 2004, he obtained his PhD from the Paris-Sud University.
Dr Monnet’s main fields of research investigation are acute circulatory failure and its treatment, haemodynamic monitoring and heart-lung interactions. Since 2001, he has signed more than 120 articles in peer-reviewed scientific journals and is the author of several didactic reviews and book chapters.
Dr. Paul Marik
Dr Marik received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa. He was an ICU attending at Baragwanath Hospital, in Soweto, South Africa. During this time he obtained a Master of Medicine Degree, Bachelor of Science Degree in Pharmacology, Diploma in Anesthesia as well as a Diploma in Tropical Medicine and Hygiene. Dr Marik did a Critical Care Fellowship in London, Ontario, Canada, during which time he was admitted as a Fellow to the Royal College of Physicians and Surgeon of Canada. Dr Marik has worked in various teaching hospitals in the US since 1992. He is board certified in Internal Medicine, Critical Care Medicine, Neurocritical Care and Nutrition Science. Dr Marik is currently Professor of Medicine and Chief of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School in Norfolk, Virginia. Dr Marik has written over 400 peer reviewed journal articles, 50 book chapters and authored four critical care books.
73 Elm St, Sudbury, ON P3C 1R7